Table 2.

Proportion of the Different Myofiber Types in the GL and OL of EOMs

	Median (Q1–Q3)
	Myofiber Type	GL	OL
Controls (n = 6)	MyHCIIa	59.59% (47.34%–78.24%)	82.13% (72.94%–82.93%)
	MyHCeom	25.98% (6.03%–34.93%)	2.40% (0.83%–12.55%)
	MyHCI	14.87% (13.58%–17.48%)	15.06% (14.07%–16.41%)
All ALS (n = 17)	MyHCIIa	31.54% (23.20%–52.30%)	73.11% (63.68%–84.92%)
	MyHCeom	52.74% (32.32%–62.99%)	9.79% (3.51%–20.39%)
	MyHCI	12.85% (11.85%–15.96%)	12.27% (10.89%–18.48%)
Spinal-onset ALS (n = 9)	MyHCIIa	44.23% (27.08%–57.69%)	74.69% (72.01%–87.52%)
	MyHCeom	43.56% (27.06%–58.51%)	7.75% (2.77%–12.58%)
	MyHCI	15.66% (12.01%–16.78%)	12.49% (10.95%–21.30%)
Bulbar-onset ALS (n = 8)	MyHCIIa	24.79% (20.10%–37.51%)	67.03% (19.40%–80.73%)
	MyHCeom	59.95% (52.86%–65.81%)	20.39% (3.98%–69.25%)
	MyHCI	12.85% (9.20%–14.44%)	11.77% (10.34%–14.57%)